Candel Therapeutics (CADL) Prepaid Assets (2020 - 2025)
Candel Therapeutics recorded quarterly Prepaid Assets of $1.7 million in Q4 2025, down 47.71% quarter-over-quarter from $3.2 million in Q3 2025, and up 44.17% year-over-year from $1.2 million in Q4 2024.
Candel Therapeutics' Prepaid Assets history runs 6 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- In Q4 2025, Prepaid Assets rose 44.17% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (up 44.17% YoY), while the FY2025 annual figure was $1.7 million, up 44.17% from the prior year.
- Prepaid Assets came in at $1.7 million for Q4 2025 at Candel Therapeutics, down from $3.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.2 million in Q3 2025 to a low of $110000.0 in Q2 2021.
- A 5-year average of $1.7 million and a median of $1.5 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 2376.34% in 2021 and tumbled 45.62% in 2024, its largest moves.
- Candel Therapeutics' Prepaid Assets stood at $2.3 million in 2021, then slipped by 18.06% to $1.9 million in 2022, then dropped by 26.66% to $1.4 million in 2023, then slipped by 16.91% to $1.2 million in 2024, then jumped by 44.17% to $1.7 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.7 million, $3.2 million, and $2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 2.92 Mn |
| Mar 31, 2025 | 983,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 1.28 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | 1.38 Mn |
| Sep 30, 2023 | 2.12 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.89 Mn |
| Jun 30, 2022 | 544,000.00 |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 2.30 Mn |
| Sep 30, 2021 | 2.57 Mn |
| Jun 30, 2021 | 110,000.00 |
| Dec 31, 2020 | 93,000.00 |